Literature DB >> 7610210

MADD rates the states: a media advocacy event to advance the agenda against alcohol-impaired driving.

A Russell1, R B Voas, W Dejong, M Chaloupka.   

Abstract

The "Rating the States" (RTS) Program of Mothers Against Drunk Driving (MADD) is designed to bring public attention to the status of State government efforts to combat alcohol-impaired driving. MADD's 1993 report, which evaluated each State with a grade from A to D, brought renewed visibility to MADD's fight for new prevention policies and helped to advance key State legislation. Because of MADD's national press conference and other media activities, more than 60 million Americans saw or heard a news story related to the program. This article outlines the program's objectives and methodology, efforts to publicize the results, and what was achieved in terms of news media coverage and in advancing public policy change. The RTS Program is a proven media advocacy strategy for prompting State legislatures and Governors to enact new policies. The article concludes with guidelines for other public health advocacy groups that may want to emulate this strategy.

Entities:  

Mesh:

Year:  1995        PMID: 7610210      PMCID: PMC1382113     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  3 in total

1.  Press coverage of public expenditure of Master Settlement Agreement funds: how are non-tobacco control related expenditures represented?

Authors:  K M Clegg Smith; M A Wakefield; M Nichter
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

2.  Association between state level drinking and driving countermeasures and self reported alcohol impaired driving.

Authors:  R A Shults; D A Sleet; R W Elder; G W Ryan; M Sehgal
Journal:  Inj Prev       Date:  2002-06       Impact factor: 2.399

Review 3.  Impact of psychotropic medications on simulated driving: a critical review.

Authors:  Mark J Rapoport; Melanie C Baniña
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.